Catalyst Pharmaceuticals Inc (CPRX)
21.68
-1.12
(-4.91%)
USD |
NASDAQ |
Nov 14, 16:00
21.55
-0.13
(-0.60%)
After-Hours: 20:00
Catalyst Pharmaceuticals Gross Profit (Annual): 346.24M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 346.24M |
| December 31, 2022 | 179.81M |
| December 31, 2021 | 118.95M |
| December 31, 2020 | 102.03M |
| December 31, 2019 | 87.55M |
| December 31, 2018 | 0.50M |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 |
| Date | Value |
|---|---|
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 | |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
87.55M
Minimum
2019
346.24M
Maximum
2023
166.92M
Average
118.95M
Median
2021
Gross Profit (Annual) Benchmarks
| Corcept Therapeutics Inc | 475.89M |
| Sarepta Therapeutics Inc | 1.093B |
| Alnylam Pharmaceuticals Inc | 1.518B |
| Biomarin Pharmaceutical Inc | 1.904B |
| Cytokinetics Inc | -322.59M |